Assessment of hyperpolarized 3He lung MRI for regional evaluation of interventional therapy: A pilot study in pediatric cystic fibrosis

Journal of Magnetic Resonance Imaging

Volumn 30, Issue 5, 2009, Pages 981-988

  Woodhouse, Neil ^a   Wild, Jim M ^a   Van Beek, Edwin J R ^a,b   Hoggard, Nigel ^a   Barker, Nicki ^c   Taylor, Christopher J ^a,c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF IOWA   (United States)

^c SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

3 helium; Cystic fibrosis; Lung; MRI

Indexed keywords

HELIUM; HELIUM 3; UNCLASSIFIED DRUG; ISOTOPE; OXYGEN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC VALUE; HELIUM 3 MAGNETIC RESONANCE IMAGING; HUMAN; HYPERPOLARIZATION; IMAGE ANALYSIS; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; LUNG VENTILATION; LUNG VOLUME; OUTCOME ASSESSMENT; PATIENT MONITORING; PHYSIOTHERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; REPRODUCIBILITY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; THERAPY EFFECT; THORAX DRAINAGE; THORAX PERCUSSION; CHEMISTRY; COHORT ANALYSIS; IMAGE PROCESSING; LUNG; MAGNETISM; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PILOT STUDY; SPIROMETRY;

ADOLESCENT; CHILD; COHORT STUDIES; CYSTIC FIBROSIS; HELIUM; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOTOPES; LUNG; MAGNETIC RESONANCE IMAGING; MAGNETICS; OXYGEN; PILOT PROJECTS; PULMONARY VENTILATION; SPIROMETRY;

EID: 70350445915     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21949     Document Type: Article

References (32)

1. Fogarty A, Hubbard R, Britton J. International comparison of median age at death from cystic fibrosis. Chest 2000;117:1656-1660. (Pubitemid 30413359)
2. Dodge JA, Lewis PA, Stanton M, Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J 2007;29: 522-526.
3. Chrispin AR, Norman AP. The systematic evaluation of the chest radiograph in cystic fibrosis. Pediatr Radiol 1974;2:101-105.
4. Brody AS, Klein JS, Molina PL, Quan J, Bean JA, Wilmott RW. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr 2004;145:32-38. (Pubitemid 38962449)
5. Boucher RC. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 2004;23:146-158. (Pubitemid 38088512)
6. Aurora P, Bush A, Gustafsson P, et al. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med 2005;171:249-256.
7. Gustafsson PM, Aurora P, Lindblad A. Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis. Eur Respir J 2003;22:972-979. (Pubitemid 37540651)
8. Horsley AR, Gustafsson PM, Macleod KA, et al. Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis. Thorax 2008;63:135-140.
9. de Jong PA, Tiddens HA, Lequin MH, Robinson TE, Brody AS. Estimation of the radiation dose from CT in cystic fibrosis. Chest 2008;133:1289-1291.
10. Altes TA, Eichinger M, Puderbach M. Magnetic resonance imaging of the lung in cystic fibrosis. Proc Am Thorac Soc 2007;4: 321-327. (Pubitemid 47330864)
11. Puderbach M, Eichinger M, Haeselbarth J, et al. Assessment of morphological MRI for pulmonary changes in cystic fibrosis (CF) patients: comparison to thin-section CT and chest x-ray. Invest Radiol 2007;42:715-725. (Pubitemid 351325904)
12. Failo R, Wielopolski PA, Tiddens HA, Hop WC, Mucelli RP, Lequin MH. Lung morphology assessment using MRI: a robust ultrashort TR/TE 2D steady state free precession sequence used in cystic fibrosis patients. Magn Reson Med 2009;61:299-306.
13. Jakob PM, Wang T, Schultz G, Hebestreit H, Hebestreit A, Hahn D. Assessment of human pulmonary function using oxygen-enhanced T(1) imaging in patients with cystic fibrosis. Magn Reson Med 2004;51:1009-1016.
14. Donnelly LF, MacFall JR, McAdams HP, et al. Cystic fibrosis: combined hyperpolarized 3He-enhanced and conventional proton MR imaging in the lung - preliminary observations. Radiology 1999;212:885-889.
15. Mentore K, Froh DK, de Lange, EE, et al. Hyperpolarized HHe3 MRI of the lung in cystic fibrosis: assessment at baseline and after bronchodilator and airway clearance treatment. Acad Radiol 2005;12:1423-1429. (Pubitemid 41512835)
16. Koumellis P, van Beek EJ, Woodhouse N, et al. Quantitative analysis of regional airways obstruction using dynamic hyperpolarized 3He MRI-preliminary results in children with cystic fibrosis. J Magn Reson Imaging 2005;22:420-426. (Pubitemid 41298331)
17. van Beek EJ, Hill C, Woodhouse N, et al. Assessment of lung disease in children with cystic fibrosis using hyperpolarized 3-Helium MRI: comparison with Shwachman score, Chrispin-Norman score and spirometry. Eur Radiol 2007;17:1018-1024.
18. McMahon CJ, Dodd JD, Hill C, et al. Hyperpolarized 3helium magnetic resonance ventilation imaging of the lung in cystic fibrosis: comparison with high resolution CT and spirometry. Eur Radiol 2006;16:2483-2490. (Pubitemid 44649697)
19. Zanche ND, Chhina N, Teh K, Randell C, Pruessmann KP, Wild JM. Asymmetric quadrature split birdcage coil for hyperpolarized 3He lung MRI at 1.5T. Magn Reson Med 2008;60:431-438.
20. Wild JM, Woodhouse N, Paley MN, et al. Comparison between 2D and 3D gradient-echo sequences for MRI of human lung ventilation with hyperpolarized 3He. Magn Reson Med 2004;52:673-678. (Pubitemid 39108983)
21. Woodhouse N, Wild JM, Paley MN, et al. Combined helium-3/proton magnetic resonance imaging measurement of ventilated lung volumes in smokers compared to never-smokers. J Magn Reson Imaging 2005;21:365-369. (Pubitemid 40446430)
22. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999;8:135-160. (Pubitemid 29425900)
23. Ireland RH, Woodhouse N, Hoggard N, et al. An image acquisition and registration strategy for the fusion of hyperpolarized helium-3 MRI and x-ray CT images of the lung. Phys Med Biol 2008;53:6055-6063.
24. Tannenbaum E, Prasad SA, Dinwiddie R, Main E. Chest physiotherapy during anesthesia for children with cystic fibrosis: effects on respiratory function. Pediatr Pulmonol 2007;42:1152-1158. (Pubitemid 350231865)
25. Lagerkvist AL, Sten GM, Redfors SB, Lindblad AG, Hjalmarson O. Immediate changes in blood-gas tensions during chest physiotherapy with positive expiratory pressure and oscillating positive expiratory pressure in patients with cystic fibrosis. Respir Care 2006;51:1154-1161.
26. Fauroux B, Boulé M, Lofaso F, et al. Chest physiotherapy in cystic fibrosis: improved tolerance with nasal pressure support ventilation. Pediatrics 1999;103:E32.
27. Eichinger M, Puderbach M, Kauczor HU, Risse F. Improved visualization of delayed regional pulmonary perfusion in cystic fibrosis patients. In: Proceedings ATS, Toronto, 2008 (Abstract 456).
28. Krauth C, Jalilvand N, Welte T, Busse R. Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies. Pharmacoeconomics 2003;21:1001-1024. (Pubitemid 37255455)
29. Bradley JM, Moran FM, Elborn JS. Evidence for physical therapies (airway clearance and physical training) in cystic fibrosis: an overview of five Cochrane systematic reviews. Respir Med 2006; 100:191-201.
30. Gustafsson PM, De Jong PA, Tiddens HA, Lindblad A. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax 2008;63:129-134. (Pubitemid 351236476)
31. Aurora P, Gustafsson P, Bush A, et al. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax 2004;59:1068-1073. (Pubitemid 39573927)
32. de Jong PA, Mayo, JR, Golmohammadi K, et al. Estimation of cancer mortality associated with repetitive computed tomography scanning (CT) scanning in cystic fibrosis. Am J Respir Crit Care Med 2005;173:199-203.